Editor-in-chief
Maria Stella Graziani

Deputy Director
Martina Zaninotto

Associate Editors
Ferruccio Ceriotti
Davide Giavarina
Bruna Lo Sasso
Giampaolo Merlini
Martina Montagnana
Andrea Mosca
Paola Pezzati
Rossella Tomaiuolo
Matteo Vidali

International Advisory Board Khosrow Adeli Canada
Sergio Bernardini Italy
Marcello Ciaccio Italy
Eleftherios Diamandis Canada
Philippe Gillery France
Kjell Grankvist Sweden
Hans Jacobs The Netherlands
Eric Kilpatrick UK
Magdalena Krintus Poland
Giuseppe Lippi Italy
☩Howard Morris Australia
Mario Plebani Italy
Sverre Sandberg Norway
Ana-Maria Simundic Croatia
☩Jill Tate Australia
Tommaso Trenti Italy
Cas Weykamp The Netherlands
Maria Willrich USA
Paul Yip Canada


Publisher
Biomedia srl
Via L. Temolo 4, 20126 Milano

Responsible Editor
Giuseppe Agosta

Editorial Secretary
Arianna Lucini Paioni
Biomedia srl
Via L. Temolo 4, 20126 Milano
Tel. 0245498282
email: biochimica.clinica@sibioc.it



Area soci
Non possiedi o non ricordi la password!
Clicca qui

BC: Articoli scritti da A. Carbucicchio

Proteina S100B ed enolasi neurone-specifica nella valutazione iniziale del trauma cranico lieve nell’adulto: pronte per il debutto nel mondo reale?
Protein S100B and neuron-specific enolase (NSE) for the initial evaluation of mild head trauma in adults: ready for prime time?
<p>Computerized tomography (CT) remains the best option for diagnosis of head trauma,&nbsp;although it carries several drawbacks. Among a large number of putative biomarkers proposed for initial evaluation&nbsp;of mild head trauma, protein S100B and NSE exhibit the best diagnostic performance. We performed a prospective&nbsp;study, where these biomarkers were assessed in 68 patients consecutively admitted to the Emergency Department&nbsp;(ED) with mild head trauma. The CT scan revealed brain lesions in 11 patients (16%). Concentrations of both&nbsp;biomarkers in serum were found to be more elevated in patients with positive CT than in those with negative scans.&nbsp;The area under the ROC curve (AUC) of protein S100B (0.89, 95% confidence interval: 0.81-0.97) was, however,&nbsp;significantly greater than that of NSE (0.77, 95% confidence interval: 0.64-0.90) (P=0.044). It was estimated that&nbsp;determination of protein S100B in all patients presenting to the ED with mild head trauma could safely save up to 50%&nbsp;CT execution, reducing the overall healthcare expenditure by ~1/3.</p>
Biochimica Clinica ; 38(3) 227-233
Opinioni - Opinions